Opiant Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today announced, as required by Nasdaq Stock Market rules,